China National Medicines Corporation Ltd.

SHSE:600511 Stock Report

Market Cap: CN¥25.9b

China National Medicines Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Guotao Tian

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownershipn/a
Management average tenure1.9yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

Nov 12
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO

Guotao Tian (53 yo)

2.5yrs

Tenure

CN¥2,550,000

Compensation

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


Leadership Team

NamePositionTenureCompensationOwnership
Guotao Tian
GM & Director2.5yrsCN¥2.55mno data
Fei Chen
Chief Financial Officer1.1yrsCN¥191.30kno data
Lichun Luo
Board Secretary2.5yrsCN¥1.15mno data
Zhang Ting
Deputy Secretary of the Party Committeeno dataCN¥371.90kno data

1.9yrs

Average Tenure

46yo

Average Age

Experienced Management: 600511's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Guotao Tian
GM & Director2.6yrsCN¥2.55mno data
Xiuchang Jiang
Chairman13.7yrsno datano data
Yong Liu
Director12.9yrsno datano data
Jingyun Liu
Chairman of the Supervisory Board12.9yrsno datano data
Luwen Shi
Independent Director2.6yrsCN¥200.00kno data
Xingxi Yu
Independent Director2.6yrsCN¥200.00kno data
Deyong Wen
Director5.5yrsno datano data
Xin Jiang
Director2.6yrsCN¥2.55mno data
Xiaojuan Li
Director2.6yrsno datano data
Kai Lu
Supervisor2.6yrsno datano data

2.6yrs

Average Tenure

53yo

Average Age

Experienced Board: 600511's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.